| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Michael P Stansky is Director at TLSI. Michael P Stansky's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $5.7M at current prices.
Net of sales, the TLSI filings show accumulation of 971,098 shares.
Michael P Stansky has 4 Form 4 filings on record from February 2026 to May 2026, all as Director at TriSalus Life Sciences (TLSI), 2026.
The 8 reported transactions were 4 open-market purchases, 2 stock awards and 2 option or other derivative awards.
Counted by filing, the open-market trades come to 2 purchases worth about $3.0M and no sales.
The largest open-market purchase was 610,000 shares of TLSI at an average $2.50 on May 15, 2026, about $1.5M.